AAAAAA

   
Results: 1-25 | 26-27
Results: 1-25/27

Authors: Salama, AD Chaudhry, AN Ryan, JJ Eren, E Levy, JB Pusey, CD Lightstone, L Lechler, RI
Citation: Ad. Salama et al., In Goodpasture's disease, CD4(+) T cells escape thymic deletion and are reactive with the autoantigen alpha 3(IV)NC1, J AM S NEPH, 12(9), 2001, pp. 1908-1915

Authors: Lai, PC Cook, HT Smith, J Keith, JC Pusey, CD Tam, FWK
Citation: Pc. Lai et al., Interleukin-11 attenuates nephrotoxic nephritis in Wistar Kyoto rats, J AM S NEPH, 12(11), 2001, pp. 2310-2320

Authors: Reynolds, J Pusey, CD
Citation: J. Reynolds et Cd. Pusey, Oral administration of glomerular basement membrane prevents the development of experimental autoimmune glomerulonephritis in the WKY rat, J AM S NEPH, 12(1), 2001, pp. 61-70

Authors: Karkar, AM Charles, JS Pusey, CD
Citation: Am. Karkar et al., Prevention and treatment of experimental crescentic glomerulonephritis by blocking tumour necrosis factor-alpha, NEPH DIAL T, 16(3), 2001, pp. 518-524

Authors: Ryan, JJ Reynolds, J Norgan, VA Pusey, CD
Citation: Jj. Ryan et al., Expression and characterization of recombinant rat alpha 3(IV)NC1 and its use in induction of experimental autoimmune glomerulonephritis, NEPH DIAL T, 16(2), 2001, pp. 253-261

Authors: Stone, JH Calabrese, LH Hoffman, GS Pusey, CD Hunder, GG Hellmann, DB
Citation: Jh. Stone et al., Vasculitis - A collection of pearls and myths, RHEUM DIS C, 27(4), 2001, pp. 677

Authors: Griffith, ME Pusey, CD
Citation: Me. Griffith et Cd. Pusey, Cellular aspects of vasculitis - T cell-mediated aspects, SPR SEM IMM, 23(3), 2001, pp. 287-298

Authors: Reynolds, J Pusey, CD
Citation: J. Reynolds et Cd. Pusey, T-cell-specific therapy in autoimmune glomerulonephritis - Authors reply, AM J KIDNEY, 38(6), 2001, pp. 1324-1328

Authors: Ryan, CJ Anilkumar, T Ben-Hamida, AJA Khorsandi, SE Aslam, M Pusey, CD Gaylor, JDS Courtney, JM
Citation: Cj. Ryan et al., Multisorbent plasma perfusion in fulminant hepatic failure: Effects of duration and frequency of treatment in rats with Grade III hepatic coma, ARTIF ORGAN, 25(2), 2001, pp. 109-118

Authors: Lord, GM Cook, T Arit, VM Schmeiser, HH Williams, G Pusey, CD
Citation: Gm. Lord et al., Urothelial malignant disease and Chinese herbal nephropathy, LANCET, 358(9292), 2001, pp. 1515-1516

Authors: Salama, AD Levy, JB Lightstone, L Pusey, CD
Citation: Ad. Salama et al., Goodpasture's disease, LANCET, 358(9285), 2001, pp. 917-920

Authors: Norden, AGW Lapsley, M Lee, PJ Pusey, CD Scheinman, SJ Tam, FWK Thakker, RV Unwin, RJ Wrong, O
Citation: Agw. Norden et al., Glomerular protein sieving and implications for renal failure in Fanconi syndrome, KIDNEY INT, 60(5), 2001, pp. 1885-1892

Authors: Robson, MG Cook, HT Botto, M Taylor, PR Busso, N Salvi, R Pusey, CD Walport, MJ Davies, KA
Citation: Mg. Robson et al., Accelerated nephrotoxic nephritis is exacerbated in C1q-deficient mice, J IMMUNOL, 166(11), 2001, pp. 6820-6828

Authors: Griffith, ME Coulthart, A Pemberton, S George, AJT Pusey, CD
Citation: Me. Griffith et al., Anti-neutrophil cytoplasmic antibodies (ANCA) from patients with systemic vasculitis recognize restricted epitopes of proteinase 3 involving the catalytic site, CLIN EXP IM, 123(1), 2001, pp. 170-177

Authors: Levy, LB Turner, AN Rees, AJ Pusey, CD
Citation: Lb. Levy et al., Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression, ANN INT MED, 134(11), 2001, pp. 1033-1042

Authors: Griffin, S Lockwood, CM Pusey, CD
Citation: S. Griffin et al., Plasmapheresis and immunoadsorption, THERAPEUTIC IMMUNOLOGY, SECOND EDITION, 2001, pp. 597-611

Authors: Watts, RA Scott, DGI Pusey, CD Lockwood, CM
Citation: Ra. Watts et al., Vasculitis - aims of therapy. An overview, RHEUMATOLOG, 39(3), 2000, pp. 229-232

Authors: Levy, JB Pusey, CD
Citation: Jb. Levy et Cd. Pusey, Nephrotoxicity of intravenous immunoglobulin, QJM-MON J A, 93(11), 2000, pp. 751-755

Authors: Dupont, PJ Lightstone, L Clutterbuck, EJ Gaskin, G Pusey, CD Cook, T Warrens, AN
Citation: Pj. Dupont et al., Lesson of the week - Cholesterol emboli syndrome, BR MED J, 321(7268), 2000, pp. 1065-1067

Authors: Tam, FWK Smith, J Agarwal, S Karkar, AM Morel, D Thompson, EM Pusey, CD
Citation: Fwk. Tam et al., Type IV phosphodiesterase inhibitor is effective in prevention and treatment of experimental crescentic glomerulonephritis, NEPHRON, 84(1), 2000, pp. 58-66

Authors: Reynolds, J Tam, FWK Chandraker, A Smith, J Karkar, AM Cross, J Peach, R Sayegh, MH Pusey, CD
Citation: J. Reynolds et al., CD28-B7 blockade prevents the development of experimental autoimmune glomerulonephritis (vol 105, pg 643, 2000), J CLIN INV, 105(7), 2000, pp. 1023-1023

Authors: Reynolds, J Tam, FWK Chandraker, A Smith, J Karkar, AM Cross, J Peach, R Sayegh, MH Pusey, CD
Citation: J. Reynolds et al., CD28-B7 blockade prevents the development of experimental autoimmune glomerulonephritis, J CLIN INV, 105(5), 2000, pp. 643-651

Authors: Tam, FWK Smith, J Morel, D Karkar, AM Thompson, EM Cook, HT Pusey, CD
Citation: Fwk. Tam et al., Development of scarring and renal failure in a rat model of crescentic glomerulonephritis, NEPH DIAL T, 14(7), 1999, pp. 1658-1666

Authors: Lord, GM Tagore, R Cook, T Gower, P Pusey, CD
Citation: Gm. Lord et al., Nephropathy caused by Chinese herbs in the Uh, LANCET, 354(9177), 1999, pp. 481-482

Authors: Cook, HT Singh, SJ Wembridge, DE Smith, J Tam, FWK Pusey, CD
Citation: Ht. Cook et al., Interleukin-4 ameliorates crescentic glomerulonephritis in Wistar Kyoto rats, KIDNEY INT, 55(4), 1999, pp. 1319-1326
Risultati: 1-25 | 26-27